既往肾下腹主动脉瘤修复后异时性胸主动脉瘤的胸主动脉腔内修复
基于血管质量倡议(VQI)2013至2022年1493例接受胸主动脉腔内修复(TEVAR)的患者,比较原发性胸主动脉瘤与既往肾下腹主动脉瘤开放或腔内修复后异时性胸主动脉瘤的围手术期结局和5年死亡率。风险调整后,既往EVAR后TEVAR的围手术期死亡率(9.7% vs 3.9%;OR 5.3;95%CI 2.3-12;P<.001)和5年死亡率(40% vs 24%;HR 2.1;95%CI 1.4-3.1;P=.001)均高于原发性TEVAR,尤其在八旬老人中更明显;而既往开放修复后TEVAR的结局与原发性TEVAR相当。
要点
- 既往EVAR后TEVAR的围手术期死亡率和5年死亡率高于原发性TEVAR。
- 八旬老人中既往EVAR后TEVAR的围手术期和5年死亡率差异更明显。
- 既往开放修复后TEVAR的围手术期死亡率、5年死亡率和院内并发症与原发性TEVAR相当。
核心结论
- 既往EVAR后接受异时性胸主动脉瘤TEVAR的患者,尤其是八旬老人,围手术期和5年死亡率更高,属于高风险群体;未来需努力识别导致这些较差结局的潜在因素,同时这些发现强调对此类高风险个体需仔细选择患者并进行适当的术前咨询。
研究设计与样本
- 回顾性队列研究,纳入血管质量倡议(VQI)2013至2022年接受降胸主动脉TEVAR的胸主动脉瘤患者,仅纳入原发性TEVAR或既往肾下开放修复(OAR)或腔内修复(EVAR)后TEVAR者,共1493例。
- 采用单变量分析比较基线和手术特征,采用逻辑回归和Cox回归进行围手术期结局和5年死亡率的多变量分析。
主要发现
- 1493例中,原发性TEVAR占81%,既往OAR后TEVAR占9.0%,既往EVAR后TEVAR占9.7%。
- 与原发性TEVAR相比,异时性胸主动脉瘤TEVAR患者更年长、男性白人更多,高血压、吸烟和肾功能不全比例更高,更常无症状且就诊时直径更大,但造影剂用量和手术时间更大。
- 风险调整后,既往EVAR后TEVAR vs 原发性TEVAR:围手术期死亡率9.7% vs 3.9%(OR 5.3;95%CI 2.3-12;P<.001),5年死亡率40% vs 24%(HR 2.1;95%CI 1.4-3.1;P=.001)。
- 八旬老人(n=375;25%)中,既往EVAR后TEVAR vs 原发性TEVAR:围手术期死亡率17% vs 8.4%(OR 6.7;95%CI 2.2-21;P=.001),5年死亡率50% vs 27%(HR 3.0;95%CI 1.5-5.7;P=.010)。
- 院内并发症包括脊髓缺血(SCI)在既往EVAR后TEVAR vs 原发性TEVAR中无显著差异(2.6% vs 2.8%;OR 1.2;95%CI 0.33-3.3;P=.77);既往OAR后TEVAR vs 原发性TEVAR的围手术期死亡率(4.4% vs 3.9%;OR 1.2;95%CI 0.32-3.8;P=.73)、5年死亡率(28% vs 24%;HR 1.3;95%CI 0.80-2.1;P=.54)和院内并发症包括SCI(2.6% vs 0.7%;OR 0.21;95%CI 0.01-1.1;P=.16)均无显著差异。
临床怎么用
- 作者认为,既往EVAR后异时性胸主动脉瘤TEVAR患者尤其是八旬老人属于高风险群体,需仔细选择患者并进行适当的术前咨询。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Thoracic endovascular aortic repair (TEVAR) of metachronous thoracic aortic aneurysms (M-TAAs) following previous infrarenal abdominal aortic aneurysm (AAA) repair has been associated with higher spinal cord ischemia (SCI) risk compared with TEVAR of primary thoracic aortic aneurysms (TAAs). However, data on the impact of the type of prior infrarenal aortic repair on outcomes are scarce. In this study, we examined perioperative outcomes and long-term mortality following TEVAR M-TAA compared with primary TEVAR of TAA. METHODS: We identified all Vascular Quality Initiative (VQI) patients who underwent TEVAR of TAA in the descending thoracic aorta from 2013 to 2022. Only patients undergoing primary TEVAR or TEVAR following infrarenal open (OAR) or endovascular (EVAR) repair were included. We performed univariate analyses to identify differences in baseline and procedural characteristics, and multivariable analyses for perioperative outcomes and 5-year mortality using logistic and Cox regression, respectively. RESULTS: We included 1493 patients who underwent primary TEVAR (81%) or TEVAR following prior OAR (9.0%) or prior EVAR (9.7%). Compared with primary TEVAR, patients undergoing TEVAR M-TAA were older, more commonly male, white, and had higher rates of hypertension, smoking, and renal dysfunction. Patients with M-TAA were more likely to be asymptomatic and have larger diameters at presentation but were exposed to greater contrast volume and procedural times relative to primary TEVAR patients. Following risk-adjustment, compared with primary TEVAR, TEVAR after prior EVAR was associated with higher perioperative mortality (9.7% vs 3.9%; odds ratio [OR], 5.3; 95% confidence interval [CI], 2.3-12; P < .001) and 5-year mortality (40% vs 24%; hazard ratio [HR], 2.1; 95% CI, 1.4-3.1; P = .001). Specifically, among octogenarians (n = 375; 25%), the perioperative and 5-year mortality differences were even more pronounced (perioperative mortality: 17% vs 8.4%; OR, 6.7; 95% CI, 2.2-21; P = .001; 5-year mortality: 50% vs 27%; HR, 3.0; 95% CI, 1.5-5.7; P = .010). However, in-hospital complications, including SCI (2.6% vs 2.8%; OR, 1.2; 95% CI, 0.33-3.3; P = .77), were not notably different. In contrast, TEVAR after previous OAR was associated with comparable perioperative mortality (4.4% vs 3.9%; OR, 1.2; 95% CI, 0.32-3.8; P = .73), 5-year mortality (28% vs 24%; HR, 1.3; 95% CI, 0.80-2.1; P = .54), and in-hospital complications, including SCI (2.6% vs 0.7%; OR, 0.21; 95% CI, 0.01-1.1; P = .16). CONCLUSIONS: Patients undergoing TEVAR of M-TAAs after prior EVAR, particularly octogenarians, have higher perioperative and 5-year mortality and therefore, represent a high-risk group. Future efforts should strive to discern the underlying factors leading to these poorer outcomes; meanwhile, these findings emphasize the need for careful patient selection and appropriate preoperative counseling in these high-risk individuals.
引用
- Yadavalli SD, Wu WW, Rastogi V, et al. Thoracic endovascular aortic repair of metachronous thoracic aortic aneurysms following prior infrarenal abdominal aortic aneurysm repair. J Vasc Surg. 2023. PMID: 37257669. doi:10.1016/j.jvs.2023.05.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。